These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
424 related items for PubMed ID: 24118002
1. The differential diagnosis of CD8-positive ("type D") lymphomatoid papulosis. McQuitty E, Curry JL, Tetzlaff MT, Prieto VG, Duvic M, Torres-Cabala C. J Cutan Pathol; 2014 Feb; 41(2):88-100. PubMed ID: 24118002 [Abstract] [Full Text] [Related]
2. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases. Kempf W, Kazakov DV, Palmedo G, Fraitag S, Schaerer L, Kutzner H. Am J Surg Pathol; 2012 Jul; 36(7):1021-9. PubMed ID: 22472952 [Abstract] [Full Text] [Related]
3. Histopathological aspects and differential diagnosis of CD8 positive lymphomatoid papulosis. Marschalkó M, Gyöngyösi N, Noll J, Károlyi Z, Wikonkál N, Hársing J, Kuroli E, Csomor J, Matolcsy A, Sarolta K, Szepesi Á. J Cutan Pathol; 2016 Nov; 43(11):963-973. PubMed ID: 27461449 [Abstract] [Full Text] [Related]
4. Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas. Kempf W, Kazakov DV, Schärer L, Rütten A, Mentzel T, Paredes BE, Palmedo G, Panizzon RG, Kutzner H. Am J Surg Pathol; 2013 Jan; 37(1):1-13. PubMed ID: 23026936 [Abstract] [Full Text] [Related]
5. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Kempf W, Kutzner H, Cozzio A, Sander CA, Pfaltz MC, Müller B, Pfaltz M. Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414 [Abstract] [Full Text] [Related]
6. Contribution of longitudinal follow up and clinical pathological correlation in the diagnosis CD30-positive skin infiltrates. De Souza A, Carter JB, Harris NL, Ferry JA, Duncan LM. J Cutan Pathol; 2015 Jul; 42(7):452-8. PubMed ID: 25931140 [Abstract] [Full Text] [Related]
7. Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases. Plaza JA, Feldman AL, Magro C. J Cutan Pathol; 2013 Feb; 40(2):236-47. PubMed ID: 23189966 [Abstract] [Full Text] [Related]
8. CD8-positive lymphomatoid papulosis (type D): Some lesions may lack CD30 expression and overlap histologically with mycosis fungoides. Simo OC, Warren SJ, Mark L, Hoffmann K, Alomari AK. Int J Dermatol; 2019 Jul; 58(7):800-805. PubMed ID: 30520526 [Abstract] [Full Text] [Related]
9. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders. Benner MF, Jansen PM, Meijer CJ, Willemze R. Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236 [Abstract] [Full Text] [Related]
10. Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders. De Souza A, Tinguely M, Pfaltz M, Burghart DR, Kempf W. J Cutan Pathol; 2014 Dec; 41(12):901-6. PubMed ID: 25353265 [Abstract] [Full Text] [Related]
12. Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin. de la Garza Bravo MM, Patel KP, Loghavi S, Curry JL, Torres Cabala CA, Cason RC, Gangar P, Prieto VG, Medeiros LJ, Duvic M, Tetzlaff MT. Hum Pathol; 2015 Apr; 46(4):558-69. PubMed ID: 25666664 [Abstract] [Full Text] [Related]